About Us

Developing a pipeline of drug + energy therapies to cure cancer

BioConvergent Health is led by a cross-disciplinary team with deep medical and scientific expertise and a long history of working together.

We have advanced the licensed assets from several, major pharmaceutical companies and academic centers, creating a diversified growth platform with multiple pathways to value creation and a new standard of care for patients and physicians.

This approach can address severe unmet needs in oncology. The Advisory Board consists of former senior executives of major global pharmaceutical companies.

Management Team

Our company is committed to aggressively expanding the boundaries of medicine by integrating these unique drug and device solutions.

FULL MANAGEMENT TEAM & ADVISORY BOARD

Gary Eichenbaum

Cofounder, Member

Chandan Guha

Cofounder, Member

Ronen Israel

Cofounder, Member

Our Commitment

At BioConvergent Health, our vision is to be at the forefront of biotechnology, revolutionizing healthcare through the integration of transformational drug-only and combination drug + energy device therapies. We aspire to optimize treatment outcomes, improve quality of life, and enable personalized care with groundbreaking solutions. By pushing the boundaries of innovation, we aim to shape a future where the convergence of therapies unleashes new possibilities and transforms the landscape of healthcare.

Ronen Israel

Cofounder, Managing Partner